You have 9 free searches left this month | for more free features.

Arthritis

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Tucson Epidemiology Study of Chronic Obstructive Lung Diseases

Completed
  • Asthma
  • +4 more
    • (no location specified)
    Feb 26, 2016

    Recurrent or Tophaceous Gout Trial in All KPNC Facilities (Control, Gout Disease Management Program)

    Completed
    • Recurrent or Tophaceous Gout
    • Control
    • Gout Disease Management Program
    • All KPNC Facilities, California
      Kaiser Permanente Northern California Medical Facilities
    Mar 4, 2015

    Atrial Fibrillation, Vascular Risk Trial in Worldwide (clopidogrel (SR25990C), )

    Completed
    • Atrial Fibrillation
    • Vascular Risk
    • clopidogrel (SR25990C)
    • placebo
    • Bridgewater, New Jersey
    • +29 more
    May 20, 2015

    Kidney Transplant Trial in Canada, United States (Everolimus and tacrolimus, mycophenolate mofetil and tacrolimus)

    Completed
    • Kidney Transplant
    • Everolimus and tacrolimus
    • mycophenolate mofetil and tacrolimus
    • Birmingham, Alabama
    • +49 more
    Oct 13, 2015

    Alzheimer Trial in France, Germany, Spain (ACC-001 + QS-21, ACC-001, QS-21)

    Completed
    • Alzheimer Disease
    • ACC-001 + QS-21
    • +3 more
    • Paris, Cedex 13 (MRI), France
    • +23 more
    Nov 30, 2015

    Alzheimer Trial in United States (ACC-001 + QS-21, QS-21, Diluent: Phosphate Buffered Saline)

    Completed
    • Alzheimer Disease
    • ACC-001 + QS-21
    • +3 more
    • Phoenix, Arizona
    • +26 more
    Nov 30, 2015

    Rheumatoid Arthritis Trial in Petah Tikva (EPAX 6000 EE 1000mg (0.6 gr DHA+EPA), Capsules (Placebo))

    Unknown status
    • Rheumatoid Arthritis
    • EPAX 6000 EE 1000mg (0.6 gr DHA+EPA)
    • Capsules (Placebo)
    • Petah Tikva, Israel
      Rabin Medical Center, Campus Beilinson
    Nov 21, 2013

    Deep Vein Thrombosis, Pulmonary Embolism Trial in Worldwide (Enoxaparin + Placebo, Apixaban + Placebo)

    Completed
    • Deep Vein Thrombosis
    • Pulmonary Embolism
    • Enoxaparin + Placebo
    • Apixaban + Placebo
    • Birmingham, Alabama
    • +106 more
    Nov 25, 2015

    Asthma Trial in Canada, United States (IMA-638, )

    Completed
    • Asthma
    • IMA-638
    • placebo
    • Birmingham, Alabama
    • +81 more
    Jan 12, 2015

    Systemic Lupus Erythematosus, Lupus Trial in Boston (pravastatin, aspirin, ramipril)

    Completed
    • Systemic Lupus Erythematosus
    • Lupus
    • Boston, Massachusetts
      Brigham and Women's Hospital, RBB Brigham Arthritis Center
    Dec 23, 2013

    Rheumatoid Arthritis Trial in Canada, United States (Etanercept, methotrexate, Sulfasalazine)

    Completed
    • Rheumatoid Arthritis
    • Loma Linda, California
    • +36 more
    Nov 7, 2013

    Diabetic Nephropathy Trial in Worldwide (PF-04634817, Placebo)

    Completed
    • Diabetic Nephropathy
    • Little Rock, Arkansas
    • +141 more
    Sep 22, 2015

    Osteoporosis Trial in Minneapolis

    Completed
    • Osteoporosis
      • Minneapolis, Minnesota
        Park Nicollet Institute
      Jan 28, 2015

      Type 2 Diabetes Trial in Canada, United States (exenatide, long acting release, exenatide)

      Completed
      • Type 2 Diabetes Mellitus
      • Encino, California
      • +24 more
      Jul 29, 2015

      Osteoarthritis, Knee Trial in Pittsburgh (Periosteal stimulation, Control-Periosteal Stimulation)

      Completed
      • Osteoarthritis, Knee
      • Periosteal stimulation
      • Control-Periosteal Stimulation
      • Pittsburgh, Pennsylvania
        Geriatric Research, Education, and Clinical Center
      Jan 22, 2015

      Intraocular Pressure Changes After Glucosamine Sulfate Consumption. Trial in Tehran (Placebo three times a day, glucosamine

      Unknown status
      • Intraocular Pressure Changes After Glucosamine Sulfate Consumption.
      • Placebo three times a day
      • glucosamine sulfate 1500 mg three times a day
      • Tehran, Iran, Islamic Republic of
        Islamic Republic OF Iran
      May 7, 2015

      Ovarian Carcinoma Trial in Afula (Cytophosphan, Celecoxib, Methotrexate)

      Terminated
      • Ovarian Carcinoma
      • Cytophosphan, Celecoxib, Methotrexate
      • Afula, Israel
        HaEmek Medical Center
      Jun 21, 2015

      Various Chemokines in the Detection and Follow up of RCC

      Unknown status
      • Clear Cell Renal Cell Carcinoma
      • patients with renal cell carcinoma
      • Haifa, Israel
        Carmel Medical Center
      Mar 4, 2015

      Rheumatoid Arthritis Trial in Moscow (REGN88, Placebo)

      Completed
      • Rheumatoid Arthritis
      • Moscow, Russian Federation
        Institute of Rheumatology under the Russian Academy of Medical S
      Sep 27, 2013

      NSCLC Trial in Worldwide (Tecemotide (L-BLP25), Single low dose cyclophosphamide, Placebo)

      Completed
      • Non-small Cell Lung Cancer
      • Tecemotide (L-BLP25)
      • +2 more
      • Fort Smith, Arkansas
      • +294 more
      Oct 19, 2015

      Acute Gout Trial in Worldwide (Canakinumab 150 mg, Triamcinolone acetonide 40 mg, Placebo to canakinumab)

      Completed
      • Acute Gout
      • Canakinumab 150 mg
      • +3 more
      • Anniston, Alabama
      • +107 more
      Dec 24, 2013

      Osteoarthritis, Knee Trial in Worldwide (Hylastan)

      Completed
      • Osteoarthritis, Knee
      • Hylastan
      • Birmingham, Alabama
      • +23 more
      Feb 4, 2014

      Osteoarthritis, Knee Trial (Cryoton ™, Control ice bag)

      Completed
      • Osteoarthritis, Knee
      • Cryoton ™
      • Control ice bag
      • (no location specified)
      Aug 4, 2015

      Colitis, Ulcerative Trial in Worldwide (Placebo, Golimumab 50 mg, Golimumab 100 mg)

      Completed
      • Colitis, Ulcerative
      • Placebo
      • +3 more
      • Birmingham, Alabama
      • +308 more
      Mar 24, 2016

      Nocturia Trial in Canada, United States (Desmopressin Melt)

      Completed
      • Nocturia
      • Desmopressin Melt
      • Scottsdale, Arizona
      • +72 more
      Nov 11, 2015